CoChat

ACE2 Activation Promotes Antithrombotic Activity

Open access
Fraga-Silva, Rodrigo A., Sorg, Brian S., Wankhede, Mamta, deDeugd, Casey, Jun, Joo Y., Baker, Matthew B., Li, Yan, Castellano, Ronald K., Katovich, Michael J., Raizada, Mohan K., Ferreira, Anderson J. · 2010 · Molecular Medicine
Cited by 133

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The aim of the present study was to test the hypothesis that the activation of the angiotensin-converting enzyme (ACE)2/angiotensin-(1-7)/Mas receptor axis by use of a novel ACE2 activator (XNT) would protect against thrombosis. Thrombi were induced in the vena cava of spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) rats, and ACE2 and ACE activity in the thrombus was determined. Real-time thrombus formation was viewed through intravital microscopy of vessels in nude mice. Thrombus weight was 40% greater in the SHR (4.99 +/- 0.39 versus 7.04 +/- 0.66 mg). This weight increase was associated with a 20% decrease in ACE2 activity in the thrombus. In contrast, there were no differences between the WKY and SHR in ACE2 protein and ACE activity in the thrombi. ACE2 inhibition (DX600; 0.1 micromol/L/kg) increased thrombus weight by 30% and XNT treatment (10 mg/kg) resulted in a 30% attenuation of thrombus formation in the SHR. Moreover, XNT reduced platelet attachment to injured vessels, reduced thrombus size, and prolonged the time for complete vessel occlusion in mice. Thus, a decrease in thrombus ACE2 activity is associated with increased thrombus formation in SHR. Furthermore, ACE2 activation attenuates thrombus formation and reduces platelet attachment to vessels. These results suggest that ACE2 could be a novel target for the treatment of thrombogenic diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2119/molmed.2009.00160

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 133

Metadata

Authors
Fraga-Silva, R. A., Sorg, B. S., Wankhede, M., deDeugd, C., Jun, J. Y., Baker, M. B., Li, Y., Castellano, R. K., Katovich, M. J., Raizada, M. K., & Ferreira, A. J.
Venue
Molecular Medicine
Published
2010-01-22
Volume
16
Issue
5-6
Pages
210-215
ISSN
  • 1076-1551 (ISSN-L)
  • 1528-3658
OpenAlex
W17887271
Cited by
133
References
2
FWCI
4.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ACE2 Activation Promotes Antithrombotic Activity. https://app.cochat.ai/papers/10.2119/molmed.2009.00160
The paper
Fraga-Silva, R. A., Sorg, B. S., Wankhede, M., deDeugd, C., Jun, J. Y., Baker, M. B., Li, Y., Castellano, R. K., Katovich, M. J., Raizada, M. K., & Ferreira, A. J. (2010). ACE2 Activation Promotes Antithrombotic Activity. Molecular Medicine. https://doi.org/10.2119/molmed.2009.00160

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.